Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated

Amman, Jordan Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading ahead of its Annual General Meeting. Riad Mishlawi, Hikma’s CEO, said: “Hikma has had a strong start to 2024, with continued growth and momentum across the Group. Our three businesses are performingContinue Reading